Jacobs Levy Equity Management, Inc Ocular Therapeutix, Inc Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
186Shares Held
136MCall Options Held
284KPut Options Held
156K-
Summer Road LLC West Palm Beach, FL13.9MShares$101 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$93.4 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$92.9 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$83.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$61.8 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $560M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...